- Indian tycoon Ajay Piramal weighs $1 billion contract pharma sale
- India needs decisive govt to take swift decision, maintain growth: Jaitley
- Delta Corp gains 8% post September quarter results
- Cryptocurrencies, blockchains and their dark side: 4 essential reads
- Total SA eyes stake in Indian LNG terminals, city gas distribution: CEO
- HEG hits new high; stock zooms 56% in 6 trading days
- Infosys extends gain ahead of September-quarter results
Showing of 1-10 from 1927 result
December 18, 2015, Friday | Technology
Co also launched Around Yu, a platform that will provide suite services to its users
June 29, 2011, Wednesday | Companies
With demand slowing considerably over the last few weeks, most car and sports utility vehicle makers are keeping production levels low and close to the retail level to suit the demand, which is set for a downward swing over the next two months.
April 12, 2011, Tuesday | Companies
Global pharma major Takeda Pharmaceutical has filed a patent infringement suit against India's second-largest drug maker Dr Reddy's in a New York Court over the latter's efforts to manufacture a generic version of acid reflux treatment drug Dexilant ...
January 04, 2011, Tuesday | Companies
Cement makers today increased the price of the commodity in Maharashtra by Rs10 per 50 kg bag in the wake of a spike in demand.
January 16, 2010, Saturday | Companies
Pharmaceutical patents are just over a fourth of all patents granted in the country, but domestic drug makers account for almost all post-grant patent opposition filed, official data reveals.
November 17, 2009, Tuesday | Companies
During the proceedings, counsels appearing for the Intel Corporation informed the division Bench headed by the Chief Justice A P Shah about their decision to withdraw the suit against the trademark registry.
August 15, 2009, Saturday | Companies
Days after suit maker Hartmarx was sold to Emerisque and its Indian partner, S Kumars Nationwide Ltd, three US plants of the clothier have been shut resulting in the loss of over 500 jobs.
August 14, 2009, Friday | Companies
Days after suit maker Hartmarx was sold to Emerisque and its Indian partner S Kumars Nationwide Ltd, three US plants of the clothier have been shut down resulting in the loss of over 500 jobs.
July 18, 2009, Saturday | Companies
Suit maker Hartmarx Corp's sale to London-based Emerisque and Indian apparel company S Kumars Nationwide Ltd has been postponed for a few days as the buyers have not been able to finalise the financial details.
June 30, 2009, Tuesday | Companies
Top three executives of Hartmarx will leave the company, as city-based suit maker, which has been acquired by Indian textile firm S Kumars Nationwide Ltd and British firm Emerisque, readies to be run by new owners.
September 07, 2004, Tuesday | Technology
Software maker 3am Labs on Wednesday announced three new remote-access products in its Logmein suite, which is aimed at mobile users.
19 minutes ago | Companies
Happy Forgings has a forging capacity of 60,000 metric tonnes (MT) and a machining capacity of 20,500 MT
7 hours ago | Technology
Lalitesh Katragadda says he is is drawn to crowdsourcing because it is essentially about people helping themselves and others solve their problems while technology is an enabler
9 hours ago | International
The money now owed by Clifford to compensate Trump team of lawyers for their work on the case over nearly six months will not be insignificant, reported NYT
18 hours ago | Current Affairs
Ramani says she was disappointed that Akbar's statement of Sunday paid no heed to the "trauma and fear of the survivors"
21 hours ago | Politics
Gandhi also accused Modi of remaining silent when Dalits, women, minorities, tribals and the poor are attacked in the country
October 15, 2018, Monday | Economy & Policy
This project aims to see 10 million homes linked to gas grids by 2020 and bring relief to smog filled cities
October 14, 2018, Sunday | Opinion
In yet another case of a fighting between a public sector firm and state authorities, the Supreme Court appointed a retired judge as the sole arbitrator
October 12, 2018, Friday | Companies
Currently there are no specific regulations governing the sale of OTC products and this impacts both patient safety and access, says OPPI